Market Overview

UPDATE: Benchmark Raises PT on Cardiovascular Systems on Fiscal 2014 Estimates

Share:
Related CSII
28 Stocks Moving In Monday's Pre-Market Session
Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3
9 Stocks Steven Cohen Keeps Buying (GuruFocus)

In a report published Friday, Benchmark Company analyst James Terwilliger reiterated his Speculative Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised his price target from $18.00 to $24.00.

In the report, Terwilliger noted, “We are publishing our fiscal 2014 revenue and EPS estimates of $125 million and ($0.78). This represents 25% revenue growth compared to our fiscal 2013 revenue estimate of $100 million. Our fiscal 2014 EPS estimate of ($0.78) compares favorably to our fiscal 2013 EPS estimate of ($1.09). The main driver of the improvement in our bottom line results is our assumption that CSII receives regulatory approval for their cardiology application with a subsequent launch in Q1:14 of calendar 2014.”

Cardiovascular Systems closed on Thursday at $20.30.

Latest Ratings for CSII

DateFirmActionFromTo
Sep 2017Raymond JamesInitiates Coverage OnMarket Perform
Jun 2017Bank of AmericaDowngradesNeutralUnderperform
Aug 2016Leerink SwannUpgradesMarket PerformOutperform

View More Analyst Ratings for CSII
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (CSII)

View Comments and Join the Discussion!

Partner Center